...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: something. anything.

Whoops - read too quickly and assumed it was for 2020.  Well, hopefully they will be presenting something this year!

  

Share
New Message
Please login to post a reply